News 2016-08-06
Porton’s Semi Annual Senior Management Working Conference August 6, 2016

Chongqing, China, August 6, 2016: Porton Fine Chemicals, Ltd. held its semi-annual senior management working conference on August 6, 2016. Led by Chairman Oliver Ju and President Andrew Xu, senior executives from the Company’s R&D, Manufacturing Operations, Planning, Business Development and Key Account Management functions and overseas subsidiaries reviewed progress made during the first half of FY 2016 and plans for the second half. Porton continues to make robust advances towards its corporate goals and service mission of helping global pharmaceutical companies more efficiently realize best health outcomes for their patients through chemical process innovation and high-quality production of custom APIs and drug intermediates.
Others
More
News 2026-08-05
Porton Advanced Secures Drug Manufacturing License (Class C), Expanding CDMO Services to Commercialization
Porton Advanced Solutions Ltd. has officially been granted a Drug Manufacturing License (Class C) by the National Medical Products Administration (NMPA). This milestone qualifies Porton Advanced to undertake commercial contract manufacturing for Cell and Gene Therapy (CGT) products, extending its CDMO services from process development and clinical production through to the commercialization stage.

News 2026-07-08
Porton Advanced's UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) Acceptance
Porton Advanced’s UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) Acceptance